| Understanding how phosphorylation and redox modifications regulate cardiac ryanodine receptor type 2 activity to produce an arrhythmogenic phenotype in advanced heart failure A Dashwood, E Cheesman, N Beard, H Haqqani, YW Wong, P Molenaar ACS Pharmacology & Translational Science 3 (4), 563-582, 2020 | 10 | 2020 |
| Effects of omecamtiv mecarbil on failing human ventricular trabeculae and interaction with (−)‐noradrenaline A Dashwood, E Cheesman, YW Wong, H Haqqani, N Beard, K Hay, ... Pharmacology research & perspectives 9 (3), e00760, 2021 | 5 | 2021 |
| Potential of β2AR for added benefit in treating heart failure through a better understanding of signaling K Walweel, E Cheesman, P Molenaar Current Opinion in Physiology, 100719, 2023 | | 2023 |
| A Bitter Taste in Your Heart: Cardiac Cells Expressing T2Rs and Polymorhpisms that Affect Cardiac Function WG Thomas, CJ Bloxham, A Dashwood, E Cheesman, KD Hulme, ... Chemical Senses 48, 2023 | | 2023 |
| Antiarrhythmic Effects of Phenytoin, a Novel Heart Failure Diastolic Ryanodine Channel Inhibitor, in Human Failing Ventricle M Spratt, A Dashwood, E Cheesman, H Haqqani, Y Wong, W Chan, ... Heart, Lung and Circulation 31, S70-S71, 2022 | | 2022 |
| A Rare Case of Severe Nontropical Isolated Right Ventricular Endomyocardial Fibrosis S Laher, YW Wong, D Platts, A Prabhu, B Thomson, C Hamilton-Craig, ... Case Reports 2 (13), 2078-2084, 2020 | | 2020 |
| Determining the Properties of Omecamtiv Mecarbil on Human Explanted Cardiac Trabeculae and Its Interaction with Current Inotropes via the Beta 1-Adrenoceptor A Dashwood, E Cheesman, Y Wong, H Haqqani, P Molenaar The Journal of Heart and Lung Transplantation 39 (4), S358, 2020 | | 2020 |
| 025 Determining the Effects of Omecamtiv Mecarbil on Human Failing Ventricular Trabeculae and Interaction With (-)-Noradrenaline Via the β1-adrenoceptor A Dashwood, E Cheesman, Y Wong, H Haqqani, P Molenaar Heart, Lung and Circulation 29, S49, 2020 | | 2020 |
